Recludix Pharma
John Yeoman is currently working as a Senior Principal Scientist in Medicinal Chemistry at Recludix Pharma. Prior to this role, John held positions at X-Chem, Inc. and Amgen, where John focused on designing and synthesizing novel bioactive compounds for various therapeutic discovery programs. John completed their Ph.D. in Organic Chemistry at Caltech after earning their Bachelor of Arts in Chemistry from Grinnell College.
This person is not in any offices
Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity.